Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Mar 05, 2024 (filed on Mar 13, 2024)Insider Name:Durbin ScottOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:23,205Price:--
-
Mar 05, 2024 (filed on Mar 13, 2024)Insider Name:Nelson SonjaOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:23,205Price:--
-
Mar 05, 2024 (filed on Mar 13, 2024)Insider Name:Pruden Gary JOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:23,205Price:--
-
Mar 05, 2024 (filed on Mar 12, 2024)Insider Name:Moran Timothy P.Ownership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:23,205Price:--
-
Sep 22, 2023 (filed on Sep 22, 2023)Insider Name:Orchestra BioMed Holdings, Inc.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Sep 06, 2023 (filed on Sep 06, 2023)Insider Name:Durbin ScottOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,500Price:--
-
Jun 21, 2023 (filed on Jun 21, 2023)Insider Name:Ram RavitOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Jun 21, 2023 (filed on Jun 21, 2023)Insider Name:Ram RavitOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Jun 21, 2023 (filed on Jun 21, 2023)Insider Name:Ram RavitOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Jun 21, 2023 (filed on Jun 21, 2023)Insider Name:Ram RavitOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
Filings by filing date
-
Mar 05, 2024 (filed on Mar 13, 2024)Insider Name:Durbin ScottOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:23,205Price:--
-
Mar 05, 2024 (filed on Mar 13, 2024)Insider Name:Nelson SonjaOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:23,205Price:--
-
Mar 05, 2024 (filed on Mar 13, 2024)Insider Name:Pruden Gary JOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:23,205Price:--
-
Mar 05, 2024 (filed on Mar 12, 2024)Insider Name:Moran Timothy P.Ownership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:23,205Price:--
-
Sep 22, 2023 (filed on Sep 22, 2023)Insider Name:Orchestra BioMed Holdings, Inc.Ownership Type:Direct OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Sep 06, 2023 (filed on Sep 06, 2023)Insider Name:Durbin ScottOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:2,500Price:--
-
Jun 21, 2023 (filed on Jun 21, 2023)Insider Name:Ram RavitOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Jun 21, 2023 (filed on Jun 21, 2023)Insider Name:Ram RavitOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Jun 21, 2023 (filed on Jun 21, 2023)Insider Name:Ram RavitOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Jun 21, 2023 (filed on Jun 21, 2023)Insider Name:Ram RavitOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
News
Biz Brief
Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 1301 E Broward Blvd Fl 3 FORT LAUDERDALE FL 33301-2152 |
Tel: | 1-518-2210106 |
Website: | https://www.motusgi.com |
IR: | See website |
Key People | ||
Timothy P. Moran Chairman of the Board | Mark L. Pomeranz President, Chief Executive Officer, Chief Operating Officer, Director | Ravit Ram Chief Financial Officer | Elad Amor Chief Accounting Officer |
Business Overview |
Motus GI Holdings, Inc. is a medical technology company. It has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation. The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles. |
Financial Overview |
For the fiscal year ended 31 December 2023, Motus GI Holdings Inc revenues decreased 46% to $319K. Net loss decreased 31% to $12.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Sales and marketing expenses -Balancing decrease of 62% to $1.6M (expense), Research and development expenses, net decrease of 36% to $3.3M (expense). |
Employees: | 15 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | N/A |
Annual revenue (TTM): | $0.32M as of Dec 31, 2023 |
EBITDA (TTM): | -$11.46M as of Dec 31, 2023 |
Net annual income (TTM): | -$12.87M as of Dec 31, 2023 |
Free cash flow (TTM): | -$11.30M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 5,210,876 as of Mar 19, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |